Objectives: Evaluate the acceptability, ceiling and floor effects, reliability, and known-group validity of the Brazilian version of the Treatment Satisfaction Questionnaire for Medication (TSQM) version 1.4 in patients with hypertension.

Methods: The sample consisted of 300 hypertensive patients undergoing treatment in an outpatient department. The acceptability was evaluated from the items not answered in the TSQM. The reliability of the TSQM was estimated through Cronbach's alpha. Known-group validity tested whether the TSQM discriminates satisfaction between different stages of hypertension, diagnoses of left ventricular hypertrophy, medication adherence, and occurrence of side effects.

Results: The TSQM had high acceptability (99% of participants answered all items). A substantial ceiling effect was found in the side effect (89%) and global satisfaction (29%) subscales. Reliability evaluated with Cronbach's alpha showed values >0.76 in all subscales. Known-group validity was supported with a statistically significant difference in patient satisfaction effectiveness between the hypertension groups and those without left ventricular hypertrophy. Regarding medication adherence, the TSQM was able to discriminate satisfaction in the side effect and global satisfaction subscales. A significantly higher satisfaction was found in all subscales of the TSQM in those patients without side effects.

Conclusions: The TSQM is a reliable and valid questionnaire to be used in Brazilians with hypertension.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vhri.2020.07.578DOI Listing

Publication Analysis

Top Keywords

known-group validity
16
tsqm
9
treatment satisfaction
8
satisfaction questionnaire
8
questionnaire medication
8
medication tsqm
8
tsqm version
8
ceiling floor
8
floor effects
8
effects reliability
8

Similar Publications

Cancer is a major health challenge globally and in Sri Lanka. Providing comprehensive information to patients is crucial for improving treatment outcomes and patient satisfaction, supported by evidence of its effectiveness in managing cancer pain. EORTC QLQ-INFO25, an information module developed by the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, is aimed at assessing cancer patients' perception of information received during different phases of care.

View Article and Find Full Text PDF

Background: Metabolic dysfunction associated fatty liver disease (MAFLD) is a highly prevalent non-communicable disease whose prevalence is reaching pandemic proportions. Its implications constitute a major public health concern. To date, no validated tool measures knowledge and attitudes towards MAFLD in young adults in the Middle East and North Africa region.

View Article and Find Full Text PDF
Article Synopsis
  • The modified Fresno test was adapted from English to Chinese to evaluate evidence-based practice knowledge and skills among physical therapists and students, as there was no existing Chinese version.
  • Phase 1 involved translating and validating the test, which showed excellent content validity.
  • In Phase 2, the test demonstrated good known-group validity, internal consistency, and test-retest reliability, confirming its effectiveness for assessing evidence-based practice in Chinese-speaking individuals.
View Article and Find Full Text PDF

Objectives: The EQ Health and Well Being is a new generic measure that captures constructs beyond health-related quality of life, with a 25-item long form (EQ-HWB) and a shorter 9-item version (EQ-HWB-S). This study aims to assess the psychometric performance of both versions in breast cancer, which is the most prevalent cancer globally, and compare them to other instruments.

Methods: A longitudinal survey in Indonesia (2023-24) with 300 female patients used the EQ-HWB, EQ-5D-5L, Functional Assessment of Cancer Therapy-General (FACT-G, from which FACT-8D was derived), Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS, from which SWEMWBS was derived).

View Article and Find Full Text PDF

Objective: To develop and assess the psychometrics of the Chronic Headache Self-Efficacy Scale (CHASE).

Background: Existing scales assess self-efficacy in coping strategies and management of symptoms and triggers but do not measure other important self-efficacy domains, such as performing daily activities and socializing in patients with chronic daily headache (CDH).

Methods: The study had two phases: (i) Development of the 14-item CHASE, with items derived from patients with CDH and a multidisciplinary healthcare team; (ii) longitudinal observational study for psychometric evaluation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!